Trials / Completed
CompletedNCT01366235
Clinical Trial for Evaluation of Ethnic Differences in Pharmacokinetics of Chloroquine, an Anti-malarial Drug
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Chloroquine is an anti-malaria agent. This study is designed to evaluate inter-ethnic differences of therapeutic effect of chloroquine and search the cause of these ethnic differences. For this purpose, chloroquine will be administered to four ethic groups of Korean, Caucasian, African and Southeast Asian and chloroquine concentration in blood will be measured. The result of this study will be helpful in finding more adequate dosing regimen of chloroquine in patients with malaria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | chloroquine phosphate 1000 mg | 1000 mg, 1day |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-10-01
- Completion
- 2011-12-01
- First posted
- 2011-06-06
- Last updated
- 2015-01-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01366235. Inclusion in this directory is not an endorsement.